DE1150073B - Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate - Google Patents

Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate

Info

Publication number
DE1150073B
DE1150073B DESCH29126A DESC029126A DE1150073B DE 1150073 B DE1150073 B DE 1150073B DE SCH29126 A DESCH29126 A DE SCH29126A DE SC029126 A DESC029126 A DE SC029126A DE 1150073 B DE1150073 B DE 1150073B
Authority
DE
Germany
Prior art keywords
methyl
testan
acetate
carbon atom
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DESCH29126A
Other languages
German (de)
Inventor
Dr Otto Engelfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DESCH29126A priority Critical patent/DE1150073B/en
Publication of DE1150073B publication Critical patent/DE1150073B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Description

Verfahren zur Herstellung von 49- Methyl-testan-17ß-ol-3-on-acetat Im Hauptpatent 1117112 ist ein Verfahren zur Herstellung von 2-monoalkylsubstituierten 3-Ketosteroiden beschrieben, welches dadurch gekennzeichnet ist, daß man 3-Ketosteroide, welche gewünschtenfalls im Molekül beliebige gegen die Einwirkung des erfindungsgemäßen Alkylierungsagens inerte Substituenten enthalten können, mit Alkylhalogeniden in Gegenwart von Natrium in flüssigem Ammoniak umsetzt. Die Alkylgruppe tritt hierbei an ein in a-Stellung zur Ketogruppe stehendes Kohlenstoffatom des Ausgangssteroids. Dieses Kohlenstoffatom ist in allen dort gegebenen Ausführungsbeispielen durchweg das Kohlenstoffatom 2.Process for the preparation of 49-methyl-testan-17ß-ol-3-on-acetate The main patent 1117112 describes a process for the preparation of 2-monoalkyl-substituted 3-ketosteroids described, which is characterized in that 3-ketosteroids, which if desired in the molecule any against the action of the invention Alkylating agents may contain inert substituents, with alkyl halides in Reacts the presence of sodium in liquid ammonia. The alkyl group occurs here to a carbon atom of the starting steroid in a position to the keto group. This carbon atom is used throughout all of the exemplary embodiments given there the carbon atom 2.

In Weiterentwicklung des Erfindungsgedankens des Hauptpatents wurde nun gefunden, daß die Alkylgruppe unter den Verfahrensbedingungen des Hauptpatents in gewissen Fällen statt an das Kohlenstoff= atom 2 an das andere, in ca-Stellung zur 3-Ketogruppe stehende Kohlenstoffatom, nämlich an das Kohlenstoff atom 4 herantreten kann, was auch bei bereits bekannten Alkylierungsverfahren festgestellt wurde. Das hängt offensichtlich von der sterischen Konfiguration am Kohlenstoffatom 5 in dem als Ausgangsstoff dienenden 3-Ketosteroid ab. Sofern das Kohlenstoffatom 5 ein a-ständiges Wasserstoffatom trägt oder wenn vom Kohlenstoffatom 5 die d4-Doppelbindung ausgeht, tritt die Alkylgruppe an das Kohlenstoffatom 2, wie in den Beispielen des Hauptpatents beschrieben. Wenn das Kohlenstoffatom 5 jedoch ein ß-ständiges Wasserstoffatom trägt, so tritt, wie nunmehr gefunden wurde, die Alkylgruppe unter den Umsetzungsbedingungen des Hauptpatentes an das Kohlenstoffatom 4, wobei die räumliche Anordnung am Kohlenstoffatom 4 vorerst noch offenbleibt.In a further development of the inventive concept of the main patent was now found that the alkyl group under the process conditions of the main patent in certain cases instead of the carbon = atom 2 to the other, in the ca position to the 3-keto group standing carbon atom, namely to the carbon atom 4 approach can, which has also been found in already known alkylation processes. That obviously depends on the steric configuration at carbon atom 5 in the 3-ketosteroid serving as the starting material. If the carbon atom 5 is an a-position Carries hydrogen atom or if the d4 double bond starts from carbon atom 5, the alkyl group occurs on carbon atom 2, as in the examples of the main patent described. However, if the carbon atom 5 carries a ß-hydrogen atom, so, as has now been found, the alkyl group occurs under the reaction conditions of the main patent to the carbon atom 4, the spatial arrangement on the carbon atom 4 remains open for the time being.

Beispiel In 600 ccm flüssiges Ammoniak werden nach Zusatz einer Spur Ferrisalz unter Rühren 2,76 g Natrium eingetragen. Nach Verschwinden der Blaufärbung gibt man eine Lösung von 15 g Testan-17ß-ol-3-on-tetrahydropyranyläther in 400 ccm Tetrahydrofuran zu. Nach 15 Stunden läßt man 10 ccm Methyljodid in 40 ccm Tetrahydrofuran zutropfen und rührt noch 4 bis 5 Stunden gut durch. Hierauf gibt man das Reaktionsgut auf Eis, säuert mit Essigsäure an und nimmt das ausgeschiedene Produkt in Äther auf. Die gewaschene und getrocknete Ätherlösung wird eingedampft und der Rückstand zwecks Pyranylätherspaltung mit wäßriger methanolischer Oxalsäurelösung behandelt. Aus dem durch Wasserzusatz ausgefällten Reaktionsprodukt wird durch fraktionierte Filtration über Aluminiumoxyd 40% Methylierungsprodukt vom nicht umgesetzten Ausgangsmaterial abgetrennt. Nach Acetylierung und Chromatographie erhält man daraus 4e-Methyltestan-17ß-ol-3-on-acetat. Das analysenreine Produkt schmilzt bei 134 bis 135°C (aus Essigester-Hexan).Example In 600 ccm of liquid ammonia, after adding a trace Ferris salt added 2.76 g of sodium with stirring. After the blue color has disappeared a solution of 15 g of testan-17β-ol-3-one tetrahydropyranyl ether in 400 ccm is added Tetrahydrofuran too. After 15 hours, 10 cc of methyl iodide is left in 40 cc of tetrahydrofuran add dropwise and stir well for another 4 to 5 hours. The reaction mixture is then added on ice, acidify with acetic acid and take the precipitated product in ether on. The washed and dried ethereal solution is evaporated and the residue treated with aqueous methanolic oxalic acid solution for the purpose of pyranyl ether cleavage. The reaction product precipitated by the addition of water is converted into fractionated Filtration through alumina 40% methylation product from the unreacted starting material severed. After acetylation and chromatography, 4e-methyltestan-17ß-ol-3-one acetate is obtained therefrom. The analytically pure product melts at 134 to 135 ° C (from ethyl acetate-hexane).

Elementaranalyse für CUH3403 Gefunden .... C 76,2 0/0, H 10,05°/a, O 14,1 0/0; berechnet .... C 76,26 0/0, H 9,89 0/0, O 13,85 0/0. Aus der 4e-Methylverbindung erhält man durch Bromierung und übliche Dehydrobromierung das bekannte e-Methyl-dl-testan-17ß-ol-3-on-acetat, F. 153 bis 154,5°C. Es erweist sich durch Mischschmelzpunkt identisch mit authentischem Material.Elemental analysis for CUH3403 Found .... C 76.2 0/0, H 10.05 ° / a, O 14.1 0/0; calcd .... C 76.26 0/0, H 9.89 0/0, O 13.85 0/0. The well-known e-methyl-dl-testan-17β-ol-3-one acetate, mp 153 to 154.5 ° C., is obtained from the 4e-methyl compound by bromination and customary dehydrobromination. It turns out to be identical to authentic material due to its mixed melting point.

Infrarot-Spektrum: dl-3-Ketogruppierung vorhanden, keine Substitution an der Doppelbindung erkennbar.Infrared spectrum: dl-3-keto grouping present, no substitution recognizable by the double bond.

Absorption im ultravioletten Licht: E230 = 8000. Damit wurde die Konstitution des verfahrensgemäß hergestellten 4e-Methyl-testan-17ß-ol-3-on-acetats bewiesen.Absorption in ultraviolet light: E230 = 8000. This proves the constitution of the 4e-methyl-testan-17ß-ol-3-one acetate produced according to the process.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von 4e-Methyl-testan-17ß-ol-3-on-acetat nach Patent 1117112, dadurch gekennzeichnet, daß man an Stelle von 3-Ketosteroiden der 5a-Reihe oder von d 4-3-Ketosteroiden Testan-17ß-ol-3-on als Ausgangsverbindung verwendet und die erhaltene 4e-Methylverbindung in an sich bekannter Weise acetyliert.PATENT CLAIM: Process for the production of 4e-methyl-testan-17ß-ol-3-on-acetate according to patent 1117112, characterized in that instead of 3-keto steroids of the 5a series or of d 4-3-keto steroids testan-17ß-ol-3-one as the starting compound used and the 4e-methyl compound obtained acetylated in a known manner.
DESCH29126A 1961-01-27 1961-01-27 Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate Pending DE1150073B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DESCH29126A DE1150073B (en) 1961-01-27 1961-01-27 Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH29126A DE1150073B (en) 1961-01-27 1961-01-27 Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate

Publications (1)

Publication Number Publication Date
DE1150073B true DE1150073B (en) 1963-06-12

Family

ID=7431333

Family Applications (1)

Application Number Title Priority Date Filing Date
DESCH29126A Pending DE1150073B (en) 1961-01-27 1961-01-27 Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate

Country Status (1)

Country Link
DE (1) DE1150073B (en)

Similar Documents

Publication Publication Date Title
DE1150073B (en) Process for the production of 4ªš-methyl-testan-17ª ‰ -ol-3-one-acetate
DE1618207C (en)
DE1172670B (en) Process for the preparation of 3-substituted D-homo-18-nor-androst-13 (17a) -en-17-one derivatives
DE1215848B (en) Fragrance
DE1670196C3 (en) Process for the preparation of 1,2-benzisothiazoles
AT266338B (en) Process for the preparation of new 17α- (3 ', 3', 3'-trifluoroprop-1'-ynyl) derivatives of estra-1,3,5 (10) -triene
DE1084707B (en) Process for the production of ª ‡ -Chlorolefinoxden
DE1300943B (en) Process for the preparation of 3-deoxygonane compounds
DE1117572B (en) Process for the production of alkyl ethers of secondary steroidal alcohols of the androstane, oestran and pregnane series
DE1793596C3 (en) 13-alkyl-gona-1,3, (10) -trienes. Eliminated from: 1443123
DE1117112B (en) Process for the preparation of 2-monoalkyl-substituted 3-ketosteroids
DE1147224B (en) Process for the preparation of monoalkyl-substituted keto steroids in ª ‡ position to the keto group
AT249892B (en) Process for the preparation of 3-oxo-Δ <4> -6-methyl-steroids
DE2101813C3 (en) New 17alpha- (2 ', 3'-difluoromethylene prop-1' -en-1 '-yl) -östra-4-en-3-ones, processes for their preparation and agents containing them
DE492321C (en) Process for the preparation of bis-ªÏ-haloacetylated diphenyl ethers
DE1493177C3 (en) 1,2alpha-methylene steroids, process for their preparation and compositions containing these substances
DE1493100A1 (en) Process for the preparation of 17-substituted 3 alpha. 4-Cyclo-6 beta. 19-ocido-5 alpha steroids
DE1188591B (en) Process for the preparation of 6beta-nitro-3alpha, 5alpha-cycloandrostan-17-one or delpetersaureesters of 3beta-hydroxyandrost-5-en-17-one
DE1643050C3 (en) 15 beta, 16 beta-methylene steroids, processes for their production and agents containing them
DE1165022B (en) Process for the preparation of monoalkyl-substituted keto steroids in ª ‡ position to the keto group
DE874916C (en) Process for the preparation of diastereomeric N-substituted 1, 3-diphenyl-3-amino-propanolen- (1)
DE1250433B (en) Process for the production of Zl2 4 steroids of the Androstan- 19-Norandrostan Pregnan or 19 Norpregnan series
DE1183501B (en) Process for the production of 18-dichloro steroids
CH493505A (en) Process for the preparation of new 17a- (3 ', 3', 3'-trifluoroprop-1'-ynyl) -17-B-hydroxy derivatives of oestra-1,3,5 (10) -triene
DE1215696B (en) Process for the preparation of 3, 4, 5-trimethoxy-benzamides and 3, 4, 5-trimethoxy-cinnamic acid amides